Device Electrophysiology

Ensite Precision

Payments companies reported to CMS as associated with Ensite Precision. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.8Massociated payments (2023-2025)
2,798clinicians with associated payments
1company reporting

By year

2023 $1.5M
2024 $829K
2025 $438K

Payments reported as associated with Ensite Precision, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $1.8M
Cardiovascular Disease $360K
Internal Medicine $134K
Interventional Cardiology $51K
Hospitalist $46K
Pediatric Cardiology $43K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Ensite Precision

These are the largest totals companies reported as associated with Ensite Precision. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Francis Marchlinski Philadelphia, PA Clinical Cardiac Electrophysiology $68,572.32
Srikanth Sundaram Littleton, CO Clinical Cardiac Electrophysiology $54,826.72
Mansour Razminia Palos Heights, IL Clinical Cardiac Electrophysiology $43,322.30
Judith Mackall Cleveland, OH Clinical Cardiac Electrophysiology $33,556.38
Matthew Hyman Philadelphia, PA Clinical Cardiac Electrophysiology $30,137.85
Jeffrey Winterfield Charleston, SC Clinical Cardiac Electrophysiology $28,263.01
Rhea Pimentel Kansas City, KS Clinical Cardiac Electrophysiology $25,760.58
Joshua Moss San Francisco, CA Clinical Cardiac Electrophysiology $24,907.98
Pasquale Santangeli Philadelphia, PA Clinical Cardiac Electrophysiology $23,896.39
Roderick Tung Chicago, IL Clinical Cardiac Electrophysiology $22,499.03

Prescribed Ensite Precision?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.